ARS Pharmaceuticals, Inc. (SPRY) Total Liabilities

Annual Total Liabilities:

$94.36M+$91.93M(+3786.12%)
December 31, 2024

Summary

  • As of today, SPRY annual total liabilities is $94.36 million, with the most recent change of +$91.93 million (+3786.12%) on December 31, 2024.
  • During the last 3 years, SPRY annual total liabilities has risen by +$77.68 million (+465.81%).
  • SPRY annual total liabilities is now at all-time high.

Performance

SPRY Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Quarterly Total Liabilities:

$225.15M+$104.00M(+85.84%)
September 30, 2025

Summary

  • As of today, SPRY quarterly total liabilities is $225.15 million, with the most recent change of +$104.00 million (+85.84%) on September 30, 2025.
  • Over the past year, SPRY quarterly total liabilities has increased by +$208.53 million (+1254.44%).
  • SPRY quarterly total liabilities is now at all-time high.

Performance

SPRY Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

SPRY Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+3786.1%+1254.4%
3Y3 Years+465.8%+5542.8%
5Y5 Years+344.0%+1787.7%

SPRY Total Liabilities Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+3786.1%at high+9173.0%
5Y5-Yearat high+3786.1%at high+9173.0%
All-TimeAll-Timeat high+3786.1%at high+9173.0%

SPRY Total Liabilities History

DateAnnualQuarterly
Sep 2025
-
$225.15M(+85.8%)
Jun 2025
-
$121.15M(+23.2%)
Mar 2025
-
$98.34M(+4.2%)
Dec 2024
$94.36M(+3786.1%)
$94.36M(+467.6%)
Sep 2024
-
$16.62M(+147.2%)
Jun 2024
-
$6.72M(+81.0%)
Mar 2024
-
$3.71M(+53.0%)
Dec 2023
$2.43M(-71.6%)
$2.43M(-78.5%)
Sep 2023
-
$11.27M(+10.5%)
Jun 2023
-
$10.20M(+1.6%)
Mar 2023
-
$10.04M
DateAnnualQuarterly
Dec 2022
$8.55M(-48.7%)
-
Sep 2022
-
$3.99M(-73.8%)
Jun 2022
-
$15.21M(-21.0%)
Mar 2022
-
$19.24M(-2.1%)
Dec 2021
$16.68M(+39.8%)
-
Dec 2021
-
$19.65M(-3.8%)
Sep 2021
-
$20.43M(+17.9%)
Jun 2021
-
$17.33M(+26.9%)
Mar 2021
-
$13.65M(+14.4%)
Dec 2020
$11.93M(-43.9%)
$11.93M(-43.9%)
Dec 2019
$21.25M(+127.3%)
$21.25M
Dec 2018
$9.35M
-

FAQ

  • What is ARS Pharmaceuticals, Inc. annual total liabilities?
  • What is the all-time high annual total liabilities for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. annual total liabilities year-on-year change?
  • What is ARS Pharmaceuticals, Inc. quarterly total liabilities?
  • What is the all-time high quarterly total liabilities for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?

What is ARS Pharmaceuticals, Inc. annual total liabilities?

The current annual total liabilities of SPRY is $94.36M

What is the all-time high annual total liabilities for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high annual total liabilities is $94.36M

What is ARS Pharmaceuticals, Inc. annual total liabilities year-on-year change?

Over the past year, SPRY annual total liabilities has changed by +$91.93M (+3786.12%)

What is ARS Pharmaceuticals, Inc. quarterly total liabilities?

The current quarterly total liabilities of SPRY is $225.15M

What is the all-time high quarterly total liabilities for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high quarterly total liabilities is $225.15M

What is ARS Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?

Over the past year, SPRY quarterly total liabilities has changed by +$208.53M (+1254.44%)
On this page